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Aldehyde oxidaseThe transition element molybdenum (Mo) needs to be complexed by a special cofactor in order to gain cat-
alytic activity. With the exception of bacterial Mo-nitrogenase, where Mo is a constituent of the FeMo-
cofactor, Mo is bound to a pterin, thus forming the molybdenum cofactor Moco, which in different variants
is the active compound at the catalytic site of all other Mo-containing enzymes. In eukaryotes, the most
prominent Mo-enzymes are nitrate reductase, sulﬁte oxidase, xanthine dehydrogenase, aldehyde oxidase,
and the mitochondrial amidoxime reductase. The biosynthesis of Moco involves the complex interaction of
six proteins and is a process of four steps, which also requires iron, ATP and copper. After its synthesis,
Moco is distributed to the apoproteins of Mo-enzymes by Moco-carrier/binding proteins. A deﬁciency in
the biosynthesis of Moco has lethal consequences for the respective organisms. In humans, Moco deﬁciency
is a severe inherited inborn error in metabolism resulting in severe neurodegeneration in newborns and
causing early childhood death. This article is part of a Special Issue entitled: Cell Biology of Metals.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Molybdenum (Mo) occurs in a wide range of metalloenzymes in
bacteria, archaea, fungi, algae, plants and animals where it forms
part of the active sites of these enzymes. However, in order to gain bi-
ological activity Mo requires the coordination by a pyranopterin, thus
forming a prosthetic group named molybdenum cofactor (Moco). Mo
has a versatile redox-chemistry that is used by the enzymes to cata-
lyze diverse redox reactions. This redox-chemistry is controlled both
by the different ligands at the Mo atom and the enzyme environment.
Mo is very abundant in the oceans in the form of the molybdate anion.
In soils, the molybdate anion is the only form of Mo that is available
for plants, fungi and bacteria. Mo-containing enzymes are essential
for life, since they hold key positions both in the biogeochemical
redox cycles of nitrogen, carbon and sulfur on Earth [1] and in the me-
tabolism of the individual organism. Hitherto more than 50 enzymes
are known to be Mo-dependent. The vast majority of them are found
in bacteria while in eukaryotes only seven have been identiﬁed [2]
Mo belongs to the group of trace elements, i.e. the organism needs
it only in minute amounts. Uptake of too high amounts of Mo howev-
er results in toxicity symptoms [3]. On the other hand unavailabilitypyranopterin monophosphate;
um cofactor; MoBP, molybde-
, nitrate reductase; SO, sulﬁte
xidase
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l rights reserved.of Mo is lethal for the organism. However, even if Mo is available
for the cell, it is biologically inactive until it becomes complexed to
form Moco.
In this article we will give a review on the current understanding
of eukaryotic Mo-metabolism, involving Mo uptake, Moco biogenesis,
Moco transfer and storage and ﬁnally its insertion into apo-
metalloenzymes. We will focus on eukaryotes because here our un-
derstanding of the cell biology of Mo is much more advanced. The
vast majority of this knowledge derives from studies in plants, fungi
and humans. Somewhat surprising the commonly used eurkaryotic
model organism yeast plays no role in Mo research as Saccharomyces
cerevisiae does not contain Mo-enzymes nor the Moco biosynthesis
pathway. Also Schizosaccharomyces pombe does not use Mo.
Genome-wide database analyses revealed a signiﬁcant number of
unicellular organisms that do not need Mo. Obviously loss of Mo-
utilization is connected to a host-associated life-style that makes
Mo-enzymes unnecessary, while all multi-cellular eukaryotes are de-
pendent on Mo [4].
2. Molybdenum uptake
Organisms take up Mo in the form of its oxyanion molybdate [5].
It requires speciﬁc uptake systems to scavenge molybdate in the
presence of competing anions. These Mo uptake systems were
studied in detail in bacteria where high-afﬁnity ABC-type trans-
porters are described consisting of three protein components and
requiring ATP-hydrolysis for operation [6]. In higher organisms,
only recently ﬁrst molybdate-transporting proteins have been
identiﬁed in algae and plants. Two proteins (Mot1 and Mot2) be-
longing to the large sulfate carrier superfamily were shown to
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across cellular membranes [7–9]. Unexpectedly, none of them was
found to reside in the plasma membrane surrounding the cell. Con-
tradictory reports localized Mot1 to the endo-membrane system
[7] or to the mitochondrial envelope [9]. A mitochondrial location
is questionable as the insertion of Mo into the Moco-backbone
takes place in the cytosol. Recently Mot2-GFP analysis indicated a
vacuolar location of this carrier protein [10]. Molybdate quantiﬁca-
tion in isolated vacuoles demonstrated that this organelle serves as
an important molybdate storage in Arabidopsis cells where Mot2
was shown to be required for vacuolar molybdate export into the cy-
tosol. This result is supported by previous work, analyzing the prote-
ome of the tonoplast where MOT2 was identiﬁed to be localized in
this cellular compartment [11]. Assuming this export function for
Mot2, the endo-membrane (ER) location of Mot1 becomes likely
since it may be involved in the transport of molybdate via the ER-
Golgi route to the vacuole. But how is molybdate imported into the
cytosol? Very recently another molybdate transporter has been
identiﬁed in the alga Chlamydomonas reinhardtii that unlike Mot1
and Mot2 is not exclusively found in algae and higher plants but
also occurs in humans [12]. Although still not localized it is likely
that this transporter serves as the general molybdate importer for
the cell. Further, it can be assumed that in addition to a possible
high-afﬁnity uptake system molybdate may also enter the cell non-
speciﬁcally through the sulfate uptake system. Molybdate uptake
through a sulfate transporter has recently been described [13], thus
supporting this assumption.
3. The molybdenum cofactor
After uptake into the cell, molybdate needs to be coordinated by
a unique scaffold in order to become biologically active. This com-
pound is a tricyclic pterin called molybdopterin or metal-
containing pterin (MPT). As the result of Mo coordination by MPT,
Moco is formed. Moco is one of two Mo-containing cofactors occur-
ring in nature. The other type of Mo-containing cofactor, the so-
called iron–molybdenum cofactor, is structurally unrelated to
Moco and is exclusively found in a single enzyme, the bacterial ni-
trogenase [14,15]. In this review, we will focus on the ubiquitously
occurring Moco.
Early work with mutants of the ﬁlamentous fungus Aspergillus
nidulans and of the higher plant Nicotiana tabacum revealed at that
time novel mutant phenotype, namely the simultaneous activity
loss of the Mo-enzymes nitrate reductase (NR) and xanthine dehy-
drogenase (XDH). Mo was the only common link between these
two – otherwise highly diverging – enzymes. Therefore it was sug-
gested that both enzymes share a common Mo-related cofactor
(Moco). Later Nason et al. [16] provided the ﬁrst piece of biochemical
evidence for a cofactor common to all Mo-enzymes that could be re-
moved as low molecular weight fraction from denatured Mo-
enzymes of mammalian, plant and bacterial origin and subsequently
incorporated into a cofactor-free apo-NR thus activating the enzyme.
The elucidation of the chemical nature of Moco is based on the work
of J.L. Johnson and K.V. Rajoagopalan [17]. Since Moco is highly sensi-
tive to oxidation, most of the work was performed using its stable ox-
idation products FormA and FormB, respectively. Hereby, Moco had
originally been identiﬁed in mammalian sulﬁte oxidase to be a pterin
derivative comprising a unique four-carbon side chain as C6 substitu-
ent [18]. The coordination of Mo via an ene-dithiolate group located
within the four-carbon side chain of the cofactor was demonstrated
by carbamidomethylation of Moco [19].
The nature of Moco structure was ﬁnally elucidated upon co-
crystallization with a Mo-enzyme aldehyde oxidase (AO) from Desul-
fovibro gigas [20]. Here, a small discrepancy to the originally proposed
Moco structure was found, namely the existence of a third ring fused
to the pterin backbone. This pyrano ring carries the ene-dithiolategroup which is essential for metal coordination (Fig. 1). Crystal struc-
tures of several Mo-enzymes from diverse species were meanwhile
solved, which in each case conﬁrmed the core structure of Moco. In-
terestingly, in Escherichia coli nitrate reductase the pyrano ring is
not closed but remains in the open conﬁguration as four-carbon
side chain. Therefore, the recently identiﬁed ring-opened dihydro
form of MPT in bacterial nitrate reductase seems to occur after cofac-
tor insertion [21].
The fusion of a pterin with a pyrano ring as identiﬁed for Moco
and its direct precursor, the metal free MPT, is unique in nature and
may have been evolved in order to maintain and/or control the spe-
cial redox properties of Mo. The pyranopterin-part of Moco is neces-
sary for the correct positioning of the catalytic metal (Mo) within
the active center of Mo enzymes and in addition to this, may also par-
ticipate in the electron channeling from or to other prosthetic groups
[22].
All analyses of Mo enzymes crystallized so far revealed that Moco
is deeply buried within the enzymes rather than being located on the
protein surface, whereby a tunnel like structure assures accessibility
of the cognate substrates [23,24]. During its life time, the Mo-
enzyme does not liberate Moco. In vitro, however Moco may be re-
moved from its protein environment either by heat treatment or by
acidiﬁcation. Once Moco is set free, it easily loses the Mo atom and
becomes rapidly oxidized, resulting in an irreversible loss of function
due to oxidation. The demolybdo-forms of Mo-enzymes are catalyti-
cally inactive.
4. Molybdenum cofactor biosynthesis
Mutations in the genes for Moco biosynthesis result in the pleio-
tropic loss of all Mo-dependent cellular processes. Early work with
A. nidulans Moco biosynthesis mutants [25] identiﬁed six genetic
complementation groups which consequently led to the proposal of
a multi-step biosynthesis pathway. Congruent with this, also in plants
a corresponding number of genetic complementation groups have
been identiﬁed among Moco deﬁcient mutants. Along with the con-
served structure of Moco, these ﬁndings provided a basis to propose
an evolutionary old multi-step biosynthetic pathway [26]. Already
in pre-genomic times, the characterization of Moco mutants contrib-
uted signiﬁcantly to our understanding of Moco biosynthesis in the
kingdoms of life, whereby among eukaryotes the biochemical and
genetic analysis of Moco mutants was most advanced in higher plants
[27]. These results laid the basis to decipher also humanMoco biosyn-
thesis [28]. Characterization of both, plant and human Moco
biosynthesis documented their strict analogy and therefore in the fol-
lowing will be compared whenever appropriate.
Moco biosynthesis can be divided into four steps, referring to the in-
termediates cyclic pyranopterin monophosphate (cPMP, previously
identiﬁed as precursor Z), MPT, adenylated MPT (MPT-AMP) and
Moco, respectively (Fig. 1). A total of six involved gene products have
been identiﬁed in plants [27], fungi [29] and humans [30–32], whereby
some but not all of the eukaryotic Moco biosynthesis genes are able to
functionally complement the corresponding bacterial mutants, thus
documenting the early evolutionary origin of Moco biosynthesis.
Different nomenclatures were introduced for genes and gene prod-
ucts involved in Moco formation. Moco biosynthesis genes and gene
products of plants followed to the cnx nomenclature (cofactor for nitrate
reductase and xanthine dehydrogenase). Human Moco biosynthesis
genes were named differently. Here, the MOCS (molybdenum cofactor
synthesis) nomenclature was introduced [30]. In the following we
will brieﬂy characterize the individual steps of Moco biosynthesis.
4.1. Step 1: Conversion of GTP to cPMP
The initial step of Moco biosynthesis starts with the conversion of
GTP to cPMP — the ﬁrst detectable intermediate of this biosynthetic
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Fig. 1. Biosynthesis of eukaryotic molybdenum cofactor. The pathway of Moco synthesis can be divided into four steps, each being characterized by its main features as given in
italics on the right side. The names for the proteins from plants (green), humans (red) and E. coli (black) catalyzing the respective steps are given. For MPT and MPT-AMP, the li-
gands of the dithiolate sulfurs are indicated by an “R” as it is currently unknown at which step copper is bound to the dithiolate. In GTP, the C8 atom of the purine is labeled with a
star. This carbon is inserted between the 2′ and 3′ ribose carbon atoms, thus forming the new C1′ position in the four-carbon side chain of the pterin (labeled with a star in cPMP).
The in vivo source of sulfur (X-S) for Cnx5 and MOCS3 is not known yet. Steps three and four in plants and humans are catalyzed by the individual domains of Cnx1 (G and E) or
Gephyrin (G and E). Functional properties like [Fe–S] clusters in Cnx2 andMocs1A, the use of S-adenosyl methionine (SAM), adenylation and sulfuration of the small subunit of MPT
synthase (Cnx7 and Mocs2B, respectively) are indicated. In Cnx5, MoeBD denotes the MoeB-like domain and RLD the rhodanese-like domain.
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with an estimated half life time of several hours at a low pH [33].
Therefore it was possible to solve its structure (E. coli) using 1H
NMR, while structural elucidation of MPT, MPT-AMP and Moco re-
quired crystallization of protein ligand complexes [34,20]. The basic
tricyclic pyranopterin structure of cPMP already resembles the fully
reduced tetrahydropterin structure of MPT and Moco [35]. However,
cPMP lacks the dithiolene moiety found in MPT, but was shown tobe hydrated at the C1′ position resulting in a geminal diol [36]. By
combining labeling studies with 1H NMR analysis it has been con-
ﬁrmed that during the conversion of GTP into cPMP each carbon
atom of the ribose and the ring atoms of the guanine are incorporated
into cPMP [37,38].
The conversion of GTP to cPMP is catalyzed by two proteins.
One of these (Cnx2 in plants, MOCS1A in humans) is a member of
the superfamily of S-adenosylmethionine (SAM)-dependent radical
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of protein and/or substrate radicals by reductive cleavage of SAM in-
volving a [4Fe–4S] cluster [40]. MOCS1A is a protein containing two
oxygen-sensitive Fe–S clusters each coordinated by only three cys-
teine residues. [39]. For the bacterial homolog (MoaA-protein in E.
coli and in Staphylococcus aureus, respectively) the complex reaction
mechanism has been deciphered in detail in [41,42]. As the plant
gene cnx2 [43] and the human gene mocs1A [31] are able to func-
tionally complement their bacterial counterpart one can assume
that the reaction mechanism is likely to occur also in eukaryotes.
The N-terminal [4Fe–4S] cluster, present in all radical SAM proteins,
binds SAM and carries out the reductive cleavage of SAM to generate
the 5′-deoxyadenosyl radical, which subsequently initiates the
transformation of 5′-GTP bound through the C-terminal [4Fe–4S]
cluster.
Both proteins catalyzing step 1 of Moco biosynthesis (plant Cnx2
and Cnx3, Fig. 1) are located in the matrix fraction of mitochondria
[44] where 5′-GTP as substrate for cPMP synthesis is available and
where Fe–S clusters as the essential prosthetic group for Cnx2 are
synthesized [45]. All subsequent steps of Moco biosynthesis, howev-
er, have been demonstrated to be localized in the cytosol [46–48].
Therefore export of cPMP from the mitochondria into the cytosol is
required, and for this task the transporter protein Atm3, which is lo-
calized in the inner membrane of plant mitochondria and belongs to
the family of ATP-binding cassette (ABC) transporters, has been
identiﬁed recently [44]. When the Atm3 exporter is mutated, cPMP
accumulates within mitochondria and the cytosol becomes short of
cPMP with the consequence that Moco levels and Mo enzyme activ-
ities decrease in the cell. The precise role of Atm3 is still unknown.
Also human cells possess this transporter protein, which is named
ABCB7.
4.2. Step 2: Synthesis of molybdopterin
The second step of Moco biosynthesis is characterized by the in-
troduction of the dithiolene function into cPMP, thus forming MPT.
This reaction is catalyzed by the enzymeMPT synthase, a heterotetra-
meric complex consisting of two small (plant Cnx7, human MOCS2B)
and two large (plant Cnx6, human MOCS2A) subunits capable of
cPMP conversion to MPT (Fig. 1). The sulfur is bound as thiocarboxy-
late to the C-terminus of the small subunit. MPT synthase converts
cPMP stoichiometrically to MPT, which most likely involves a two
step mechanism that was deciphered in detail in bacteria where the
existence of a mono-sulfurated intermediate has been observed
[49]. Again, like in step 1, also the reaction mechanism of MPT
synthase is conserved between bacteria and higher organisms as, at
least for the large subunits, proteins can be exchanged between
organisms.
The formation of MPT is not a catalytic reaction, therefore MPT
synthase needs to be regenerated upon each reaction step. This sepa-
rate resulfuration is catalyzed by the enzyme MPT-synthase sulfurase
(Cnx5 and MOCS3, respectively; Fig. 1), and at this stage the sulfur
transfer reaction in higher organisms appears to involve different
protein components as the eukaryotic genes cannot complement
their bacterial counterparts. MPT-synthase sulfurase is a two-
domain protein consisting of a N-terminal adenylating domain (ho-
mologous to E. coli MoeB) and a C-terminal rhodanese-like domain.
In analogy to the bacterial mechanism [50], this enzyme is supposed
to activate the small subunit of MPT-synthase by adenylation fol-
lowed by sulfur transfer thus forming the thiocarboxylate at the C-
terminus of the small subunit. For the human enzyme it was shown
that the sulfur comes from the rhodanese-like domain of MPT-
synthase sulfurase where it is bound as persulﬁde [47,51]. Therefore
MPT-synthase sulfurase can be seen as a multi-functional protein
combining the adenylation reaction (carried out by its N-terminal do-
main) with the subsequent sulfur transfer reaction (carried out by itsC-terminal rhodanese-like domain) (Fig. 1) representing a good ex-
ample of product-substrate channeling during the evolution of this
complex biosynthetic pathway. In humans, the cysteine desulfurase
Nfs1 is a likely candidate to function as sulfur donor for the MOCS3-
catalzyed resulfuration step [52].
4.3. Step 3: Molybdenum insertion starts with adenylation
of molybdopterin
MPT is the backbone of Moco. Physiologically active Moco consists
of both Mo and MPT, where Mo is coordinated by the dithiolene func-
tion of MPT. In cellula, the insertion of Mo into MPT is not a spontane-
ous process but is catalyzed by a Mo-insertase. Mutants defective in
this step accumulate MPT but can be partially rescued when growing
them on molybdate enriched media, thus representing an assay tool
to identify Mo-insertase mutants. Physiological Mo concentrations,
however, are not sufﬁcient to achieve any non-catalyzed Mo ligation
by MPT.
In bacteria, Mo insertion is carried out by two separately
expressed proteins (MogA and MoeA) while higher organisms have
fused these two proteins to a single two-domain protein (Cnx1 in
plants and Gephyrin in mammals). These two domains are named
G-domain (homologous to MogA) and E-domain (homologous to
MoeA) (compare Fig. 1). Work with the Mo-insertase Cnx1 from
the model plant Arabidopsis thaliana assigned different mechanistic
functions to each of these domains. Structural studies revealed a
novel biosynthetic intermediate, adenylated MPT (MPT-AMP) [34].
Consequently, the metal insertion reaction has to be subdivided
into two separate steps, starting with the adenylation of MPT. The
recombinantly expressed and puriﬁed G-domain of Cnx1
(=Cnx1G) was shown to be sufﬁcient for MPT-AMP synthesis
which occurs in a Mg2+- and ATP-dependent manner. Consequently,
MPT-AMP synthesis has been functionally attributed to the Cnx1G
domain [53,54].
4.4. Step 4: Molybdenum insertion and crosstalk to copper metabolism
Upon synthesis on the Cnx1G domain, MPT-AMP is subsequently
transferred to the E-domain domain of Cnx1 (=Cnx1E). Cnx1E cata-
lyzes the insertion of Mo into the dithiolene group of MPT yielding
physiologically active Moco. This ﬁnal step of Moco maturation essen-
tially depends on the cooperative binding of MPT-AMP and Mo to
Cnx1E which subsequently catalyzes the Mg2+-dependent hydrolysis
of MPT-AMP coupled with the insertion of Mo into the dithiolene
group of MPT (Fig. 1). Not only plant mutants [55] defective in Cnx1
and mammalian mutants defective in its homolog Gephyrin [56],
but also fungal CnxE mutants show a molybdate-repairable pheno-
type, i.e.Moco biosynthesis can be restored at least partially by grow-
ing the mutant cells on media containing unphysiologically high
concentrations (1–10 mM) of molybdate [57], thus overriding the ef-
fect of the mutation.
Upon structural elucidation of the Cnx1G MPT-AMP complex in
plants, copper (Cu1+) was identiﬁed as an intermediate ligand of
the MPT dithiolate sulfurs [34]. Therefore, insertion of Mo into the
MPT dithiolene group can be characterized as metal exchange reac-
tion, with Cu presumably serving as suitable leaving group. Beside
this function, copper might also protect the MPT dithiolate from oxi-
dation. Consequently, it is reasonable to assume that Cu is bound to
the MPT dithiolene group directly after the latter has been formed
in the second step of Moco biosynthesis. Since Cu occurs exclusively
protein bound in vivo it is likely that both, Cu binding to MPT and
its exchange for Mo, depend on yet unidentiﬁed cytoplasmic chaper-
ones involved in cellular Cu metabolism.
Subsequent in vitro work with the puriﬁed Cnx1G–MPT complex
documented an inhibitory effect of CuCl2 on Moco synthesis at a con-
centration as low as 1 μM [34], thus representing a second line of
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inhibitory inﬂuence of Cu is most likely due to the Cu-mediated inhi-
bition of the Mg2+-dependent Mo insertion reaction. Coincidently,
also pyrophosphatases are known to be inhibited by copper [58].
An obvious conclusion from these ﬁnding is that Moco deﬁciency
cannot be viewed as an isolated defect but must be seen in context
with cellular Cu metabolism, since increased cellular Cu concentra-
tions might be causal for a decreased rate of Moco synthesis. Patients
suffering from Wilson's disease possess enhanced cellular copper
concentrations, which ﬁnally leads to Cu accumulation in liver and
brain followed by a severe damage of these organs [59]. It may be
speculated that some of the symptoms may be attributed to an un-
derlying Moco deﬁciency. But also Cu shortage below physiological
levels may be detrimental for Moco biosynthesis. Therefore, when
studying Cu homeostasis the accompanying analysis of Mo metabo-
lism could shed further light onto the link between Mo and Cu
homeostasis.
5. Crosslink of molybdenum insertion to neuroreceptor anchoring
Historically, the plant Mo-insertase Cnx1 has served as search
model to identify its human homolog. Upon this, two surprising re-
sults were uncovered: (1) the protein was already known but with
a completely Mo-unrelated function, namely as neuronal anchor pro-
tein Gephyrin necessary for clustering of inhibitory glycine receptors
in the postsynaptic membrane of neurons. Gephyrin anchors the re-
ceptor proteins on the underlying cortical cytoskeleton [60]. (2) The
two domains had an inversed orientation as compared to the plant
protein Cnx1 (plants have the E domain on the N-terminus, in mam-
mals it is the G domain). Clearly the E and G domains were fused at
least two times during evolution indicating the high pressure and
functional beneﬁt of having the adenylation function and the metal
insertion function coupled into one protein thus providing an excel-
lent product-substrate channeling. As a result of different domain ori-
entations, the resulting linking-peptides evolved differently and
therefore it is not surprising that in the human protein Gephyrin a
so-called central domain developed harboring binding sites for a
number of different proteins essential for receptor clustering. Al-
though having an inversed domain orientation, the same mechanism
of Mo insertion seems to operate during Moco synthesis in plant and
mammalian insertases since Gephyrin cDNA was able to rescue Cnx1-
deﬁcient plant mutants [32]. Coincident with this observation,
gephyrin knockout-mice displayed both, Moco deﬁciency manifested
primarily in lacking sulﬁte oxidase (SO) activity and hyperekplexia
(a failure of inhibitory neurotransmission) [61]. The gephyrin gene
is ubiquitously expressed and possesses 11 alternatively spliced
exons identiﬁed in mouse [62] and men [63]. Some of the splice var-
iants display a tissue speciﬁc distribution which was assumed to be
potentially connected to neuronal related and Moco biosynthesis re-
lated functions, respectively. In recent work, this question has been
addressed and the Gephyrin splice variants involved in Moco biosyn-
thesis have been identiﬁed [64]. As a second conclusion from this
work, it was suggested that synaptic gephyrin is not involved in
Moco biosynthesis, thus implementing that scaffolding and metabolic
functions exist independent from each other. As the anchoring func-
tion is evolutionary younger it must have been recruited from the
older in Mo metabolism.
6. Micro-compartmentalization of Moco biosynthesis and
cytoskeleton binding
Not only Gephyrin, but also its plant homolog Cnx1 exhibits func-
tional properties that are distinct from Moco biosynthesis. The plant
Mo-insertase Cnx1 was shown to interact with actin ﬁlaments in
vitro [65]. Further characterization revealed that actin binding is ex-
clusively mediated by its E-domain. Most interestingly also Gephyrinwas shown to bind actin ﬁlaments via this domain [66]. Interaction of
Gephyrin with the cytoskeleton is clearly linked to its function in
postsynaptic receptor anchoring— but what could be the signiﬁcance
of a cytoskeleton binding of Cnx1? We assume that during evolution
it became important to facilitate product-substrate ﬂow, which could
result in micro-compartmentalization of a hypothetical Moco biosyn-
thetic multi-enzyme complex. After having left the mitochondrion,
the ﬁrst intermediate cPMP becomes further processed by MPT-
synthase in the cytosol. Indeed we know that MPT-synthase (catalyz-
ing step 2 of Moco biosynthesis) and Cnx1 (catalyzing steps 3 and 4)
undergo tight protein–protein interaction in the ctyosol (R. Hänsch
and R. Mendel, unpublished). Thus one can assume that MPT-
synthase directly sequesters the newly formed MPT to Cnx1 where
it becomes converted to mature Moco. Comparing the stability of
the two Moco intermediates MPT and cPMP, MPT is the more labile
one [33]. Clearly, the channeling of MPT within a multi-enzyme com-
plex would protect and stabilize this fragile compound. On the other
side, cPMP as the ﬁrst Moco intermediate seems to be stable enough
to survive its export from the mitochondria.
7. Storage, transfer and insertion of the molybdenum cofactor
For most prosthetic groups there is a gap of knowledge in our un-
derstanding how – upon synthesis – these groups are directed to their
various cellular destinations and how they ultimately ﬁnd the way
into their correct cognate proteins, or whether they are stored after
synthesis. Intricate mechanisms can be assumed to control distribu-
tion, trafﬁcking, and insertion into proteins as most of these prosthet-
ic groups are extremely ‘fragile’ and air-sensitive. For Moco in higher
organisms, some pieces of such a sorting machinery became known in
recent years.
Moco is extremely sensitive to oxidation [67], and therefore it is
assumed that Moco occurs permanently protein-bound in the cell.
Also the fast and directed ﬂow of Moco to its target enzymes is an es-
sential prerequisite to reduce the threat of Moco degradation. Both
preconditions may be met by Moco binding proteins (MoBP) ensur-
ingMoco binding as well as its directed transfer to cognate target en-
zymes. Thus, a pool of insertion-competent Moco may be stored and
provided on demand. Storing of Moco may be essential for the cell in
order to ﬂexibly meet the variable demand for Moco arising from
newly synthesized Mo-enzymes. Among eukaryotes, a ﬁrst MoBP
which was named Moco carrier protein (MCP) was identiﬁed in the
green algae C. reinhardtii [68]. Biochemical characterization of re-
combinant MCP revealed its capability to protect bound Moco
against degradation and demonstrated its reversible Moco binding
characteristics [69,70]. C. reinhardtii MCP is puriﬁed as homotetra-
meric protein where each monomer holds one molecule of Moco.
The corresponding structure was found to resemble the Rossman
fold [70]. Subsequently, a structure-based homology search identi-
ﬁed a family of eight MCP-related proteins in A. thaliana [71]. Their
biochemical characterization showed reversible Moco binding prop-
erties, however with overall lower afﬁnities. Therefore these MoBPs
are no good candidates to serve as Moco storage proteins. Rather
they seem to be involved in the cellular distribution of Moco since
they were found to undergo protein–protein interactions both with
the ‘Moco-donor’ protein Cnx1 and the ‘Moco-user’ protein NR,
thus integrating the MoBP proteins into the cellular Moco ﬂow
(Fig. 2). The high number of eight expressed MoBP proteins in
Arabidopsis probably points toward an organ and tissue speciﬁc
functional specialization.
The principles underlying Moco insertion into eukaryotic Mo-
enzymes are still not understood. Since Moco is deeply buried within
the holo-enzymes it needs to be incorporated prior to or during com-
pletion of folding and dimerization of the apoprotein monomers. In
bacteria, a complex of proteins synthesizing the last steps of Moco
biosynthesis donates the mature cofactor to apo-enzymes assisted
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has a private chaperone available, e.g. NarJ for E. coli nitrate reductase
[72] and XDHC for xanthine dehydrogenase from Rhodobacter capsu-
latus [73] and Comamonas acidovorans [74]. However, so far no eu-
karyotic Moco chaperons have been identiﬁed yet. As we have two
classes of Mo enzymes in higher organisms also differences in the in-
sertion of Moco might be considered.
8. Evolutionary link between molybdenum cofactor biosynthesis
and ubiquitin
Moco biosynthesis is an evolutionary old and highly conserved
biosynthetic pathway. Deciphering individual steps of this pathway
always involved structural analyses which provided essential contri-
butions to our current understanding. Crystallization of the small sub-
unit of the E. coli MPT synthase MoaD however revealed another
unexpected and fascinating ﬁnding. The structure of this protein
showed a high similarity to ubiquitin [75]. But not only structural
similarities were identiﬁed, also the ATP-dependent mechanism by
which ubiquitin and the small subunit of MPT synthase are activated,
turned out to be similar. Coincident with that, the terminal double
glycine motif crucial for ubiquitin functionality is present in MoaD.
Likewise, the bacterial MPT synthase sulfurase MoeB that is necessar-
ily required for the activation of MoaD, displays homology to the en-
tire region of the N-terminal part of the ubiquitin-activating enzyme
UbA1 from S. cerevisiae [76,77]. A similar mechanism for adenylate-
dependent activation was found for proteins ThiS and ThiF during thi-
amine biosynthesis in E. coli [78,79]. These similarities suggest that
the evolutionary younger ubiquitin system belongs to an evolution-
ary older family of pathways as diverse as Moco and thiamine
biosynthesis.
9. Mo deﬁciency in plants
Among higher organisms, Mo deﬁciency has been studied in detail
only in plants. The Mo content of plants is directly correlated to the
bioavailability of Mo in the soil. The lower the soil pH, the less avail-
able is Mo thus causing Mo deﬁciency where plants develop a charac-
teristic phenotype including lesions and altered morphology of leaves
[80]. Mo deﬁciency could also be caused by a mutation in the Mo-
speciﬁc uptake system [81].Mot1 knockout mutants showed a slight-
ly altered growth pattern [9,7]. As there are, however, several Mo
transporters in a plant cell a severe phenotype has not yet been
reported.
Finally, Mo deﬁciency can be caused by a defect in Moco biosyn-
thesis which has dramatic consequences for the cell since all Mo-
enzyme activities are lost or at least strongly reduced. The loss of
which Mo-enzyme is most severe for the plant? (1) Loss of NR-
activity is lethal when respective mutants are cultured with nitrate
as sole nitrogen source [82,83]. (2) The loss of SO activity results in
no phenotype provided the plants are not challenged to an atmo-
sphere with high concentrations of sulfur dioxide [84]. (3) Likewise
the loss of XDH activity has no lethal consequences although the phe-
notype of respective plants is slightly, but not dramatically changed
(F. Bittner and R. Mendel, unpublished). (4) For AO, only a mutation
in the AAO3 isoform is communicated [85]. AAO3 generates the phy-
tohormone abscisic acid, hence its loss leads to wilted leaves. A
knockout in one of the two mARC proteins has no obvious phenotype
(F. Bittner and R. Mendel, unpublished). Moco-sulfurase (ABA3) deﬁ-
ciency was found to be basically ascribed to the reduction of abscisic
acid levels due to the lack of AO activities [86,87] and hence the phe-
notype of wilted leaves. In summary, the complete loss of Moco as it
occurs in cnx mutants is lethal and leads to the death of plants
when they are grown in soil. In cell culture, however, these mutants
can be kept alive (as cripple plants) when grown on media with re-
duced nitrogen as N-source.10. Molybdenum cofactor deﬁciency and therapy in humans
Higher organisms do not tolerate loss of Moco synthesis since es-
sential metabolic functions are Mo-dependent. Human Moco deﬁ-
ciency is a rare recessive hereditary disorder (incidence below
1:100,000), which ultimately results in the death of affected patients.
Hitherto different mutations resulting in Moco deﬁciency have been
identiﬁed and found to affect three of four human Moco synthetic
genes: mocs1, mocs2 and gephyrin [28]. Lack of Moco biosynthesis re-
sults in the pleiotropic loss of all Mo-dependent enzyme activities. As
seen in other inborn errors of metabolism, symptoms develop shortly
after birth, when the babies' metabolism starts to operate and toxic
metabolites accumulate within the body. The major cause for the ob-
served clinical symptoms is the deﬁciency of SO that protects the or-
ganism – in particular the brain – from elevated levels of toxic sulﬁte
which is formed upon degradation of sulfur-containing amino acids
and sulfo-lipids. Babies born with either isolated SO or Moco deﬁcien-
cy display severe neurologic abnormalities, seizures and dysmorphic
features of brain and head. In humans, a combined deﬁciency of
Mo-enzymes was ﬁrst described by Duran [88] and hitherto, more
than 100 cases have been diagnosed. Since it is expected that many
cases remain un-recognized, the actual incidence is estimated to ex-
ceed this number.
Major advances in the understanding of Moco deﬁciency came
from a mouse model. Two thirds of the patients affected by Moco de-
ﬁciency turned out to have a defect in the ﬁrst step of Moco biosyn-
thesis, i.e. the conversion of GTP to cPMP [89], encoded by themocs1
gene. Therefore this gene was chosen to be knocked out in the ani-
mal model [90]. Subsequent characterization of the homozygous
mocs1 knockout mice revealed a severe phenotype resembling all
biochemical characteristics of human Moco deﬁciency-patients.
Since mocs1-deﬁcient mice lack the ability to synthesize cPMP, it
was decided to establish a suitable therapy using cPMP puriﬁed
from E. coli. cPMP has been injected into the liver of Moco-
deﬁcient mice, which resulted in a dramatically increased survival
time [91]. Thus treated mice developed normally, gained weight
and reached adulthood and fertility like their wild-type littermates.
First human exposure of cPMP treatment has been reported recently
[92]. A patient with Type A Moco deﬁciency has been diagnosed on
day 6 of life and experimental treatment was started on day 36 of
life. Within days, urinary biomarkers of SO and XO deﬁciency
returned to almost normal readings and stayed constant. Clinically,
the patient became more alert few days after treatment start, con-
vulsions and twitching disappeared within the ﬁrst two weeks.
Today, with nearly four years of treatment, the patient shows
delayed neurological development due to preexisting brain injury,
however, is free of seizures, happy, and alert (G. Schwarz pers.
communication).11. Molybdenum enzymes
Mo-enzymes are essential constituents of the global carbon, sul-
fur and nitrogen metabolism, since they catalyze the key reactions
underlying these pathways. The vast majority of all known (>50)
Mo-enzymes was identiﬁed in bacteria. Among them, prominent
enzymes such as the dissimilatory NR and the formate reductase
have been characterized in detail. Eukaryotes possess only a limited
number of Mo-enzymes. However XDH, AO, and SO have been iden-
tiﬁed in all eukaryotes analyzed so far. In turn, NR was only found in
autotrophic organisms (i.e. plants, algae and fungi). As a basic prin-
ciple, Mo-enzymes catalyze reactions that involve the two electron
transfer from or to a substrate which is accompanied by the transfer
of an oxygen atom derived from or incorporated into water [22,93].
In the course of this reaction the oxidation state of Mo varies from
IV to VI.
Fig. 2. Organization of biosynthesis, distribution, and maturation of Moco in plant cells. The basic steps of Moco biosynthesis are shown starting from GTP to Moco, including Moco
biosynthesis enzymes. Biosynthesis starts with conversion of GTP to cPMP in the mitochondria. The dependence of Cnx2 on [Fe–S] is indicated. The transporter Atm3 is involved in
export of cPMP to the cytosol where MPT-synthase, consisting of Cnx6 and Cnx7, is sulfurated by Cnx5, with the primary sulfur donor of Cnx5 (X-S) being unknown. It is assumed
that copper (Cu) is inserted directly after dithiolene formation. The individual reactions of the Mo-insertase Cnx1 and its products (Moco, pyrophosphate, AMP, copper) are indi-
cated. Molybdate for this reaction is supplied by the vacuolar exporter Mot2 (a Mot2-mutant leads to shortage of molybdate in the cytosol and to the accumulation of molybdate in
the vacuole). The Mot1-transporter is likely to be located in the endoplasmic reticulum, while the major cellular Mo-importer Mot should reside in the plasma membrane which,
however, has not been shown yet. Also the sulfate transporter SHTS1 is depicted which transports molybdate as well. Mature Moco can be either bound to a Moco binding protein
(MoBP), or directly to the Mo-enzymes. The Moco-sulfurase ABA3 is known to generate a protein-bound persulﬁde, which is the source of the terminal sulfur ligand of Moco in
enzymes of the XDH/AO family. Like Cnx2, XDH and AO also depend on [Fe–S] from mitochondria.
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tion chemistry of the pterin-bound Mo atom. Two different types of
Mo coordination can be found (Fig. 3): (1) The di-oxo Mo-enzymes
generally harbor a strictly conserved cysteine residue necessary for
the formation of a charge transfer bond to the pterin-coordinated
Mo atom, while remaining Mo coordination spheres are occupied by
oxygen atoms. Most prominent members of this class of Mo-
enzymes are NR and SO. This family of Mo-enzymes is also referred
to as SO-class of Mo-enzymes. (2) In contrast, the mono-oxo Mo-
enzymes do not display any protein-dependent Mo coordination.
However, here one of the Mo oxygen ligands has been replaced by a
sulfur ligand. Thus, Mo coordinates two oxygen and one sulfur
atom. XDH and AO are prominent members of this enzyme family
which is referred to as the XO-class of Mo-enzymes. Also pyridoxal
oxidase and nicotinate hydroxylase belong to this class, but they
were exclusively found in Drosophila melanogaster [94] and A. nidu-
lans [95], respectively. For Drosophila it may be assumed that pyridox-
al oxidase represents an isoform of AO. In the following, we will
brieﬂy summarize the functions and physiological roles of eukaryotic
Mo-enzymes.
11.1. Nitrate reductase
Nitrate reductase (NR, EC 1.6.6.1) catalyzes the ﬁrst step of nitrate
assimilation — the reduction of nitrate to nitrite. Eukaryotic NR iscomposed of several domains (Fig. 3). Three of them are involved in
prosthetic group binding (Moco, heme and FAD, respectively). Adja-
cent to these domains, NR has one dimerization domain and another
subdomain that is involved in NAD(P)H binding. Each eukaryotic NR
displays the same domain organization with an N-terminal Moco do-
main followed by a heme-binding cytochrome b5 domain and a C-
terminal FAD-binding domain. The individual domains are linked by
solvent-exposed linker regions called hinge I and hinge II respectively
(Fig. 3). In plants, hinge I possesses a conserved serine residue which
upon phosphorylation mediates contact with a 14-3-3 protein subse-
quently leading to inhibition of enzymatic activity [96,97]. As another
regulatory region of plant NR the N-terminal extension preceding the
Moco domain was shown to be involved in the post-transcriptional
regulation by light [98].
NR activity is dependent upon either NADH or NADPH serving as
electron donors. NADH-speciﬁc forms of NR are most abundant in
higher plants and algae, while NADPH-speciﬁc forms exclusively
occur among fungi. However, bispeciﬁc forms, capable of using
NADH as well as NADPH, have been found in all these organisms,
but predominantly occur in fungi [99]. The intramolecular electron
transfer starts with the reductive half-reaction, characterized by the
reduction of FAD by NAD(P)H. Subsequent to this in the oxidative
half reaction, electrons are transferred (via cytochrome b5) to the
Mo active site. Here, the reduction of nitrate to nitrite takes place,
with the concurrent release of hydroxide [100]. Further reduction of
Heme FADNR
HemeSO
MocomARC
NAD(P)H
Moco Dim.
Moco Dim.
Fe-S Fe-S FAD MocoXDH
AO Fe-S Fe-S FAD
Dim.
Moco Dim.
A
B
Fig. 3. Domain structure of eukaryotic Mo-enzymes. (A) Enzymes of the SO-family of
Mo-enzymes. SO as depicted represents the animal form, SO from plants (not
shown) is lacking the heme domain. The mARC enzyme most likely belongs to the
SO-family, but ﬁnal evidence needs to be provided. (B) Enzymes of the XO-family of
Mo-enzymes. Below the domain structure, the Mo-center of the respective enzyme
family is shown.
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trite may also be reduced to nitric oxide by the NR itself. However, the
intrinsic capability of NR to produce nitric oxide is very low. Nitric
oxide has been suggested to inﬂuence plant growth development,
protection against cytotoxicity of reactive oxygen species (ROS) and
plant pathogen resistance [101,102].
11.2. Sulﬁte oxidase
The enzyme SO (EC 1.8.3.1) is important for sulﬁte detoxiﬁcation,
i.e. the oxidation of sulﬁte to sulfate. Among eukaryotes, different
forms of SO developed during evolution. The animal type SO consists
of two domains binding different prosthetic groups. It comprises an
N-terminal heme-(cytochrome b5) binding and a C-terminal Moco-
binding domain [103] (Fig. 3). Its counterpart from plants however
lacks the N-terminal heme domain and harbors Moco as the sole
prosthetic group [104,105]. As a ﬁrst exception of this rule, recently
in the green alga C. reinhardtii an animal type SO has been identiﬁed
[106].
Sulﬁte oxidation is characterized as a two electron transfer reac-
tion in which electrons derived from sulﬁte reduce the Mo-center
from MoVI to MoIV [103]. The SO reaction mechanism however is
the same for both the plant type and the animal type SO except theutilized electron acceptor. Human SO uses cytochrome c as electron
acceptor and coincident with this was shown to be localized in the
mitochondrial intermembrane space. Plant SO, however, is a peroxi-
somal enzyme [107] that uses molecular oxygen as electron acceptor
and simultaneously forms hydrogen peroxide during catalysis
[108,109]. The latter fact might explain the peroxisomal localization
of SO since excess hydrogen peroxide generated during sulﬁte oxida-
tion can easily be eliminated by catalase.
While human SO catalyzes the ﬁnal step in the degradation of
sulfur-containing amino acids, the physiological role of plant SO has
been clariﬁed only recently. As sulﬁte is a strong nucleophile that
can react with a wide variety of cellular components it was assumed
that SO has a sulﬁte-detoxifying function and is required for remov-
ing excess sulﬁte from the cell. In support of this, it was found that
SO-deﬁcient plants are more susceptible to high concentrations of
sulﬁte while SO-overexpressing plants are more tolerant to excess
sulﬁte. [110,111]. Under normal conditions, SO is suggested to be
part of a sulfate–sulﬁte cycle that is essential for ﬁne-tuning of sulfur
distribution in the cell [112].
11.3. Xanthine dehydrogenase
XDH (EC 1.17.1.4.) is the key enzyme of purine degradation. It ox-
idizes hypoxanthine to xanthine and xanthine to uric acid. Like all
Mo-enzymes, XDH is a functional dimer composed of two identical
subunits [103]. Each of the XDH subunits comprises three distinct do-
mains necessary for the binding of two [2Fe–2S] clusters, FAD and
Moco, respectively (Fig. 3), while the domain necessary for dimeriza-
tion is fused to the Moco-binding domain. Members of the XO family
have a broad substrate spectrum, and therefore hydroxylate a large
number of aldehydes and aromatic heterocycles. Electrons derived
upon substrate conversion are fed into the intramolecular electron
transfer chain of the enzyme and go from the Mo center via the
[2Fe–2S] clusters to the FAD cofactor. Here electrons are either trans-
ferred to NAD to form NADH, or they are transferred to molecular ox-
ygen, thus yielding superoxide anions [113].
In contrast to plant XDH, animal XDH can be converted into the
XO form. This enzyme is no longer capable to accept NAD as electron
acceptor but uses molecular oxygen instead. Conversion of human
XDH into the XO form is mediated by two conserved cysteine residues
(reversible [114] or irreversible by limited proteolysis [115]). Other
than plant XDH, mammalian XDH can also form hydrogen peroxide
when molecular oxygen is the ﬁnal electron acceptor [116]. Plant
XDH was found to catalyze also substrate-independent ROS forma-
tion due to an intrinsic NADH oxidase activity [117]. Therefore, XDH
is discussed not only to decompose purines but also to have addition-
al physiological functions in ROS metabolism connected to plant–
pathogen interactions [118,119], hypersensitive response [120],
drought stress [113] and natural senescence [121,122]. Human XO is
proposed to be also part of a number of other physiological functions
like the inﬂammatory response to ischemia–reperfusion [123] and
the formation of milk fat droplets [124,125].
11.4. Aldehyde oxidase
AOs are XDH-related molybdo-ﬂavoenzymes that have derived
from XDH upon an ancient gene duplication [126]. Coincident with
this, both enzymes display a high degree of sequence similarity and
use the same prosthetic groups (Fig. 3). AOs display a much broader
substrate speciﬁcity than XDH, covering aromatic and aliphatic het-
erocycles and aldehydes as well as purines and pteridines. However,
major differences exist concerning the substrate binding at the Mo-
center and the physiological electron acceptor [103]. Other than
XDH, AO is a strict oxidase being unable to bind NAD but exclusively
using molecular oxygen as electron acceptor. Differences exist also
between the plant and the animal enzyme: While animal AO
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during catalysis, plant AO exclusively generates hydrogen peroxide.
The physiological function of animal AO remains open. On the
basis of the very broad (>100) substrate spectrum a general role
in biotransformation and detoxiﬁcation can be assumed. AO was
also suggested to participate in the metabolism of neurotransmit-
ters and in the formation of retinoic acid [127]. More details are
known about the functions of plant AO. In the model plant A. thali-
ana four AO genes, AAO1–AAO4 were identiﬁed whose products
form homodimers as well as heterodimers, thereby leading to al-
tered substrate speciﬁcities of the respective isoenzymes. One of
the known AO isoforms is AOδ which is necessary for the oxidation
of abscisic aldehyde yielding the phytohormone abscisic acid [128].
Abscisic acid is essential for many developmental processes and a
variety of abiotic and biotic stress responses [129]. Therefore AO is
vitally important for a number of physiological processes in plants
including the onset of senescence. Other AO isoenzymes were im-
plicated in the biosynthesis of auxin phytohormones during early
stages of plant development.
11.5. Mitochondrial amidoxime reducing component
The mitochondrial amidoxime reducing component (mARC) is the
latest eukaryotic Mo-enzyme identiﬁed as yet. The enzyme was found
in the outer membrane of pig liver mitochondria [130]. Subsequent
analyses revealed highest sequence similarity to the C-terminal do-
main of Moco sulfurase proteins. In general, all eukaryotic genomes
known encode two mARC isoforms and the enzymes have been char-
acterized from humans [131], pigs [130] and C. reinhardtii [132].
However as yet the native substrate has not been identiﬁed for either
of them. HumanmARC proteins were shown to catalyze the reduction
of many N-hydroxylated substances which are commonly used as
prodrugs, thus connecting mARC proteins with prodrug conversion.
And they were also suggested to be involved in NO-formation [133].
Coincident with the mitochondrial localization of human mARC pro-
teins, for each of them a N-terminal mitochondrial pre-sequence
was identiﬁed.
mARC proteins bind Moco as a sole prosthetic group. However,
they do not exhibit enzymatic activity on their own but depend on
the combined action of cytochrome b5 as electron transmitter and
NADH/cytochrome b5 reductase as electron donor, thus forming a
mARC enzyme complex (for review see [134]). mARC proteins
most likely belong to the SO-family, but ﬁnal evidence needs to be
provided.
12. Post-translational maturation of AO and XDH
Enzymes of the XO-family contain a terminal sulﬁdo group as
third ligand in their active center. To gain enzymatic activity, this sul-
fur atom is added to the enzyme in a ﬁnal maturation step, catalyzed
by the Moco sulfurase (ABA3 in plants, HMCS in humans; Fig. 2).
ABA3 is a homodimeric two-domain protein [135] with its N-
terminal domain sharing structural and functional homologies to bac-
terial cysteine desulfurases, thereby being more similar to SufS than
to NifS or IscS. In a pyridoxal phosphate-dependent manner, the N-
terminal domain of ABA3 decomposes L-cysteine to yield alanine
and elemental sulfur [136], the latter being bound as a persulﬁde to
a highly conserved cysteine residue of ABA3 (Fig. 2). The C-terminal
domain of ABA3 shares a signiﬁcant degree of similarity to the
newly discovered mARC proteins and was shown to bind sulfurated
Moco, which receives the terminal sulfur via an intramolecular per-
sulﬁde relay from the N-terminal domain [137,138]. It is likely that
subsequent to Moco-sulfuration, ABA3 exchanges non-sulfurated for
sulfurated Moco thus activating its target Mo-enzyme.
Under physiological aspects the terminal sulfuration step provides
an efﬁcient way of regulating the amount of active XDH and AOenzymes in the cell. Both enzymes produce physiologically active
compounds like hormones (by AO) and ROS (by AO and XDH)
whose concentrations can rapidly be increased by changing the ratio
of inactive and active XDH and AOmolecules. In fact, a rapid induction
of the aba3 genewas found upon drought and salt stress in Arabidopsis
as well as upon ABA treatment [135,87].
13. Molybdenum metabolism is linked to iron metabolism
There are at least three links connecting Mo metabolism to Fe
homeostasis.
Link 1: Fe plays an important role for the synthesis of Moco as
Cnx2 (human MOCS1A), which is involved in step 1 of Moco bio-
synthesis, requires two Fe–S clusters of the [4Fe–4S] type
(Fig. 2). These clusters are essentially involved in the formation
of cPMP [39] and have to be preassembled in the mitochondria,
where mitochondrial as well as extramitochondrial (Fe–S) clus-
ters originate from [139].
Link 2: Subsequent to step 1 of Moco biosynthesis which is located
in the mitochondria, the intermediate cPMP is exported to the cy-
tosol. As outlined in Section 4.1, the transporter protein Atm3 is
associated with this step [44] (Fig. 2). This transporter has obvi-
ously a dual function: it not only exports cPMP but also an as yet
unidentiﬁed precursor for Fe–S cluster synthesis in the cytosol
[140]. Therefore mutants in the Atm3 exporter become short of
both cPMP and Fe–S clusters in the cytosol with the consequence
that all enzymes needing these prosthetic groups decrease in
activity.
Link 3: BothMo-enzymes XDH and AO depend on Fe in the form of
[2Fe–2S] clusters, whereas NR requires Fe in the form of heme
(Fig. 3). Summarizing the Mo–Fe link it becomes evident that
Moco biosynthesis and the functioning of the majority of Mo-
enzymes in higher organisms is strictly dependent on Femetabolism
for providing Fe–S clusters and heme groups. Any impairment of Fe
metabolism would immediately affect Mo metabolism as well.
14. Conclusion and outlook
Now that the basic principles of Moco biosynthesis are under-
stood, future research will focus on the mechanistic details of the sin-
gle reactions. For example the role of Cnx2/MOCS1A in the formation
of cPMP is still unclear, and the requirement of copper in Moco bio-
synthesis is important to understand. In higher organisms, the steps
beyond Moco biosynthesis are less well known and, therefore, re-
search will also focus on Moco transport, allocation and insertion
into apo-enzymes. Here one has to keep the cellular context in
mind as Moco biosynthesis occurs to be micro-compartmentalized
in a multiprotein-biosynthesis complex localized in the cytosol of
the cell. The question of whether Moco biosynthesis is regulated to
meet the changing demands of the cell for Moco is completely open.
The systems of molybdate uptake into the cell are in need of further
research in particular in plants where we have three transporters
with different subcellular localizations. In addition the ﬁnal matura-
tion step which activates XDH and AO needs to be investigated. Also
the role of other homeostatic circuits, such as Fe and Cu metabolism,
awaits further investigation, which could address questions regarding
the pathophysiology of related metabolic disorders.
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